Cochlear Limited announced it has received US Food and Drug Administration (FDA) clearance and CE Mark accreditation for the new CochlearTM Baha® 6 Max Sound Processor, designed to improve hearing outcomes for people with singlesided deafness, conductive or mixed hearing loss. With a fitting range of up to 55 dB SNHL (sensorineural hearing level) in the same small size as current 45 dB devices1, the Baha 6 Max is the first of its kind: a premiumpower bone conduction sound processor designed for powerful hearing performance. The Baha 6 Max is the first bone conduction sound processor to offer direct streaming from Apple® and AndroidTM devices2. Direct streaming from Apple devices has been available in the Baha 5 Sound Processor since 2015. The new processor provides additional power in the smallest form1,3 and is designed to provide the clearest, richest and most natural sound possible, reducing the need to choose between hearing performance and size.